Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/1995
08/03/1995WO1995020652A1 Method of determining the activity of a regulatory factor, and use of the method
08/03/1995WO1995020651A1 Protein modifying enzyme
08/03/1995WO1995020607A1 Mercury binding polypeptides and nucleotides coding therefor
08/03/1995WO1995020605A1 Immuno-stimulatory monoclonal antibodies
08/03/1995WO1995020601A1 Reagents binding vinculin, dynein, and glutathione s-transferase from peptide libraries
08/03/1995WO1995020594A1 Purification of plant-derived polynucleotides
08/03/1995WO1995020404A1 Triplex-forming paired-ion oligonucleotides and methods for preparing and using same
08/03/1995WO1995020401A1 Polyclonal antibody libraries
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020396A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995WO1995020318A1 Ancient organisms
08/03/1995WO1995020317A1 Method for making universal donor cells
08/03/1995WO1995017508A3 Glutamate receptor (or eaa receptor) polynucleotides and their uses
08/03/1995WO1995015971A3 Nucleic acid mediated electron transfer
08/03/1995WO1995015391A3 Aspergillus expression system
08/03/1995WO1995014768A3 Method for extracting nucleic acids from a wide range of organisms
08/03/1995WO1995012660A3 Recombinant p53 adenovirus methods and compositions
08/03/1995WO1995007918A3 Pyrimidine derivatives for labeled binding partners
08/03/1995DE19502584A1 Detection method for at least one regulatory factor
08/03/1995CA2182499A1 Folding proteins
08/03/1995CA2182380A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies
08/03/1995CA2182311A1 Transgenic non-human mammals with progressive neurologic disease
08/03/1995CA2182278A1 Methods for the production of modified plants
08/03/1995CA2182269A1 Ancient organisms
08/03/1995CA2182217A1 Comparative gene transcript analysis
08/03/1995CA2182214A1 Thermostable variants of neutral proteases of bacillus stearothermophilus and bacillus thermoproteolyticus
08/03/1995CA2182206A1 Human dna mismatch repair proteins
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182190A1 Mercury binding polypeptides and nucleotides coding therefor
08/03/1995CA2182170A1 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995CA2181602A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof
08/03/1995CA2181563A1 Protein modifying enzyme
08/03/1995CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995CA2180726A1 Receptor specific bacterial adhesins and their use
08/03/1995CA2180528A1 Inhibitors of geranylgeranyl-protein transferase
08/03/1995CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/02/1995EP0665293A2 Method of determining base sequence of nucleic acid
08/02/1995EP0665291A1 Host-vector system for the expression of glucose oxidase
08/02/1995EP0665290A2 Process for gene transfer into plant cells
08/02/1995EP0664835A1 Novel plants and processes for obtaining them
08/02/1995EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies
08/02/1995EP0664814A1 Lipopolysaccharide-binding and neutralizing peptides
08/02/1995EP0664710A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF
08/02/1995EP0527184B1 Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
08/02/1995EP0522030B1 Hepatitis b vaccine
08/02/1995EP0419571B1 Dna amplification and subtraction techniques
08/02/1995EP0316444B1 Yeast expression vector
08/02/1995CN1106066A Biotin biosynthesis in bacillus subtilis
08/01/1995US5438129 DNA purification by solid phase extraction using partially fluorinated aluminum hydroxide adsorbant
08/01/1995US5438128 Method for rapid purifiction of nucleic acids using layered ion-exchange membranes
08/01/1995US5438127 DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane
08/01/1995US5437994 Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
08/01/1995US5437990 Selective amplification of target polynucleotide sequences
08/01/1995US5437988 Expression and secretion of mature human beta interleukin-1 in Bacillus subtilis and means and methods for its achievement
08/01/1995US5437986 Ferementing bacteria in broth, disrupting and cooling; adding acid and incubating to inactivate bacteria to inhibit emission of live bacteria while centrifuging; increased purity
08/01/1995US5437978 Nucleotide fragments as primers for polymerase chain reaction used in detection of toxic shock or methicillin-resistant bacteria, kits
08/01/1995US5437977 DNA probe signal amplification
08/01/1995US5437974 DNA sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/01/1995US5437951 A genetic construct comprising a PAPILLOMAVIRUS L1 gene; vaccines, diagnostic kits; genetic engineering
08/01/1995US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
08/01/1995US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization
08/01/1995CA2141392A1 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
08/01/1995CA2054607C Method for preparing transformed plant
08/01/1995CA1336493C Pharmaceutically active combination of plasminogen activator and thrombin inhibitor
07/1995
07/29/1995CA2140698A1 Expression system, integration vector and cell modified by said vector
07/27/1995WO1995020055A1 NUCLEIC ACID PROBES FOR THE DETECTION OF $i(HAEMOPHILUS INFLUENZAE)
07/27/1995WO1995020049A1 Herpesvirus pre-(viral dna replication) enveloped
07/27/1995WO1995020048A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
07/27/1995WO1995020047A2 Production of acariogenic sugar substitutes
07/27/1995WO1995020046A1 Plant aconitases and nucleic acids coding therefor
07/27/1995WO1995020045A1 Antibodies to egf receptor and their antitumour effect
07/27/1995WO1995020044A1 Natural resistance associated macrophage protein and uses thereof
07/27/1995WO1995020043A1 Inhibition of vacuolar h+ -atpase by phosphorothioate oligonucleotides
07/27/1995WO1995020042A1 Embryonic stem cell isolation
07/27/1995WO1995020039A2 Customized proteases with altered transacylation activity
07/27/1995WO1995019993A1 Protein kinases
07/27/1995WO1995019992A1 Compositions and methods using unbound mpl receptor for stimulating platelet production
07/27/1995WO1995019991A1 New composition of glycoprotein isoforms having follicle stimulating activity
07/27/1995WO1995019988A1 Materials and methods relating to proteins that interact with casein kinase i
07/27/1995WO1995019987A1 A new sensitive method for quantifying active transforming growth factor-beta and compositions therefor
07/27/1995WO1995019986A1 cDNAs ENCODING PROTEINS CLOSELY RELATED TO OPIOID RECEPTORS
07/27/1995WO1995019985A1 Haemopoietic maturation factor
07/27/1995WO1995019805A1 Electroporation and iontophoresis apparatus and method for insertion of drugs and genes into cells
07/27/1995WO1995019799A1 Gas driven gene delivery instrument
07/27/1995WO1995019793A1 Hematopoietic cell expansion and transplantation methods
07/27/1995WO1995019791A1 Radiolabeled annexins
07/27/1995WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4
07/27/1995WO1995019788A1 Inhibitors and target molecule co-localization
07/27/1995WO1995019785A1 Treatment for juvenile diabetes
07/27/1995WO1995019769A1 Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth
07/27/1995WO1995019698A1 Phytophthora resistance gene of catharanthus and its use
07/27/1995WO1995017511A3 Mycobacteria virulence factors and a method for their identification
07/27/1995WO1995015395A3 Nucleoside analogue method
07/27/1995WO1995014778A3 Dna sequence coding for a bmp receptor
07/27/1995WO1995012677A3 Immunodominant human t-cell epitopes of hepatitis c virus
07/27/1995WO1995011975A3 Retroviral superantigens, superantigen peptides, and methods of use
07/27/1995WO1995010616A3 USE OF α-1,4-GLUCAN LYASE FOR PREPARATION OF 1,5-D-ANHYDROFRUCTOSE
07/27/1995DE4424762C1 Ribozyme library in optimised expression cassette
07/27/1995CA2181711A1 New composition of glycoprotein isoforms having follicle stimulating activity
1 ... 3751 3752 3753 3754 3755 3756 3757 3758 3759 3760 3761 3762 3763 3764 3765 3766 3767 3768 3769 3770 3771 ... 4023